Schaub Hall, Campus Box 7624
Raleigh, North Carolina, 27695, United States
NCT Number: NCT05119153
The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Raleigh, North Carolina, 27695, United States
This is a single-blinded, randomized partial block design conducted over 6 weeks in two parts.
In part 1 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a beverage containing 50 g of glucose.
In part 2 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a standardized breakfast (corn flakes cereal + skim milk) containing 50 g of glucose.
In each part, fasting and postprandial glucose profiles were determined.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placebo designed to mimic coffee color.
12 oz light roast coffee
12 oz medium roast coffee
12 oz dark roast coffee
Time frame: 6 weeks
Each week, fasted baseline and postprandial measurements taken out to 240 minutes
Time frame: 6 weeks
Used glucose changes over 240 minutes to construct area under the curve
North Carolina State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686939
Glucose Metabolism Disorders, Glycemic Control
Taizhou, Zhejiang, China
View Trial DetailsNCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT07669389
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chiang Rai, Changwat Chiang Rai, Thailand
View Trial DetailsNCT04001049
Brain Diseases, Brain Ischemia
Madrid, Spain
View Trial Details